Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects. - Wikidata - awgldk - TriplyDB

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

http://www.wikidata.org/entity/Q37609869

about

Reviewing the recommendations for lupus in children.

P2860

Q38374309-D19A1539-2391-482A-B882-F94CCF87E623

P2860

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

http://www.wikidata.org/entity/Q37609869

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

@en

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

@nl

type

label

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

@en

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

@nl

prefLabel

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

@en

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

@nl

P1433

Q37609869-69403486-9D36-496D-A571-4403E3CB00E7

P1476

Q37609869-042B74CE-0642-4D75-BC01-A752113D9E29

P2093

Q37609869-16419285-99C1-4F29-9920-F7C188E5375E

Q37609869-1A7B32FA-602F-470B-8153-61FAE5FFD676

Q37609869-3B965883-6FE9-416D-80A5-BD54C06AF214

Q37609869-557D3745-C3C4-4297-BA41-FDE3D99BE93D

Q37609869-9E6BC8B2-1E9E-40D8-BEE3-308274CF1793

Q37609869-C8CFACEB-9BF8-49C7-ACED-68369788D735

Q37609869-F3F3FC80-29D3-477A-AC60-400E1FFCFAF6

P275

Q37609869-FE5B63B1-EA0D-461E-B5C0-A95844AFE362

P2860

Q37609869-017E5204-39A9-4B01-8D93-946080C4244B

Q37609869-0833049E-3F84-4493-89F4-74F269A020AF

Q37609869-0A3800E8-5738-4725-9B4E-F60DACFC2DF3

Q37609869-0C936804-F662-48CC-9C8D-EFE204823F02

Q37609869-0CF3CDE3-51C9-41E7-B381-630B69688C3C

Q37609869-116BD8B4-4E01-4C15-8590-E55253C7D2E8

Q37609869-121CD32E-0821-41F2-82FB-CF6CAF417F49

Q37609869-167514EA-38B4-48D6-ABA3-D6DF2F8FF31E

Q37609869-1E14681D-5A0E-481E-B850-2BF5C58AD6C4

Q37609869-1E7D967B-2B01-4BCA-A090-3B8A1198B4B1

P304

Q37609869-6C951BC2-1D8C-4E4C-BFA3-AEA549C337A8

P31

Q37609869-3F7C968B-D5C7-4C0D-BBFC-9705C5BE480E

Q37609869-8E84E5B6-4939-4F10-AB01-A4624E4DD373

P356

Q37609869-6B1FD791-A1D2-48EF-B07D-523BBC46B3F9

P433

Q37609869-73D40EEE-F4B2-4349-B581-63A4D5AC47F7

P478

Q37609869-D14E574A-A91A-4721-87FF-A2D12B936B56

P5008

Q37609869-28909A73-BEDC-4E7D-987C-1B4896D002E3

P577

Q37609869-C19BF5DA-13DC-46F9-9706-6F18B4AE96B7

P5875

Q37609869-139B4930-8A41-421B-8ECA-0F17806F13BF

P698

Q37609869-98C4BBA9-136C-4D57-A506-2980EDE2CF7C

P921

Q37609869-062B3DFB-A814-4207-AE99-61AD2E9613CF

Q37609869-2283233D-F737-4693-821F-8AEDBF109305

P932

Q37609869-303388A9-B943-49F5-9FE8-1034F5ADCF66

P356

ABD1806-4841.20142146

P1433

Anais Brasileiros de Dermatologia

P1476

Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.

@en

P2093

Ana Karine F da Trindade C Pereira

http://www.w3.org/2001/XMLSchema#string

Eutilia Andrade Medeiros Freire

http://www.w3.org/2001/XMLSchema#string

Jucélio Pereira Moura Filho

http://www.w3.org/2001/XMLSchema#string

Ligiana Leite de Carvalho

http://www.w3.org/2001/XMLSchema#string

Lívia Gomes Martins

http://www.w3.org/2001/XMLSchema#string

Raiza Luna Peixoto

http://www.w3.org/2001/XMLSchema#string

Sillas Duarte de Melo

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden

Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus

Clofazimine: a review of its medical uses and mechanisms of action

The 1982 revised criteria for the classification of systemic lupus erythematosus

Cutaneous lupus erythematosus: a review.

Panniculitis. Part II. Mostly lobular panniculitis.

Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations.

Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.

Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus.

Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus.

P304

118-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/ABD1806-4841.20142146

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260809719

http://www.w3.org/2001/XMLSchema#string

P698

24626656

http://www.w3.org/2001/XMLSchema#string

P921

systemic lupus erythematosus

cutaneous lupus erythematosus

P932

3938362

http://www.w3.org/2001/XMLSchema#string